Genetic Technologies Core

" My lab has used the Advanced Genetic Technologies Core services continuously for the past seven years. The reagents that they provided were critical in our research. The Advanced Genetic Technologies Core team has put a large effort to provide us with good, quality reagents in a timely manner. I am very impressed with customer service and dedication of the team. "
Emilia Galperin
About the Core

The Advanced Genetic Technologies Core provides a range of services related to the manipulation and delivery of nucleic acids to biological systems. Services include, but are not limited to:

  • Production and titering of recombinant viral vectors
  • Subcloning
  • Tagging of open reading frames
  • Development of plasmids and/or RNAs for CRISPR/Cas manipulation
  • piggyBac transposon delivery systems
  • Real-time PCR analysis
  • Recombineering
  • In vitro transcription  

 The Core maintains an extensive stock of plasmids that provide components for building constructs envisioned by the investigator and provides consultative services to devise an effective plan for their realization. We can also provide monoclonal antibodies directed against the HA, myc, and FLAG tags.

The Core also provides training opportunities in the technologies described above, either as a for-credit, one-semester class or on a project-related, fee-based basis.

Current charges for the services provided by the Core are summarized below. Projects requiring the purchase of specialized reagents not currently available in the Core may incur additional material fees.

To apply to use the Genetic Technologies Core, or for further information, click here:

Apply to Core


SnapGene ®

The Genetic Technologies and Protein cores are now offering a service called SnapGene. SnapGene is a program which allows researchers to plan, visualize, and document their molecular biology procedures. To learn more about the program, go to:

Important: This service is only available to University of Kentucky researchers.

For access to SnapGene, please contact Dr. Michael Mendenhall.